iANTHUS CAPITAL HOLDINGS (ITHUF) Liabilities and Shareholders Equity (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Liabilities and Shareholders Equity came in at $255.8 million in Q1 2026, down 6.12% year-on-year from $272.5 million in Q1 2025, and little changed quarter-over-quarter from $256.0 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Liabilities and Shareholders Equity across 7 years of filings, most recently posting $255.8 million for Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $255.8 million, down 6.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 billion (down 4.67% YoY), and the FY2025 annual result was $256.0 million, down 5.56% from the prior year.
- Liabilities and Shareholders Equity came in at $255.8 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, roughly flat from $256.0 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $364.3 million in Q2 2022 to a low of $255.8 million in Q1 2026.
- The 5-year median for Liabilities and Shareholders Equity is $273.8 million (2024), against an average of $289.8 million.
- Across the five-year window, Liabilities and Shareholders Equity advanced 0.21% in 2022 and decreased 19.45% in 2023, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Liabilities and Shareholders Equity stood at $303.5 million in 2022, then slipped by 8.59% to $277.4 million in 2023, then fell by 2.29% to $271.0 million in 2024, then retreated by 5.56% to $256.0 million in 2025, then retreated by 0.06% to $255.8 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $255.8 million (Q1 2026), $256.0 million (Q4 2025), and $255.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.04 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.15 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.71 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 555.95 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.91 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.22 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.26 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.27 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.35 Bn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | 255.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 255.84 Mn |
| Dec 31, 2025 | 255.99 Mn |
| Sep 30, 2025 | 255.95 Mn |
| Jun 30, 2025 | 268.68 Mn |
| Mar 31, 2025 | 272.53 Mn |
| Dec 31, 2024 | 271.04 Mn |
| Sep 30, 2024 | 271.18 Mn |
| Jun 30, 2024 | 272.43 Mn |
| Mar 31, 2024 | 273.78 Mn |
| Dec 31, 2023 | 277.41 Mn |
| Sep 30, 2023 | 286.11 Mn |
| Jun 30, 2023 | 293.44 Mn |
| Mar 31, 2023 | 297.53 Mn |
| Dec 31, 2022 | 303.47 Mn |
| Sep 30, 2022 | 348.03 Mn |
| Jun 30, 2022 | 364.30 Mn |
| Mar 31, 2022 | 359.70 Mn |
| Dec 31, 2021 | 344.99 Mn |
| Sep 30, 2021 | 364.00 Mn |
| Jun 30, 2021 | 363.52 Mn |